The Ophthalmology Times® EyeCon 2021 is not to be missed!

Impaired vision is a common disorder in the United States, with an estimated 12 million Americans aged 40 and older living with reduced vision. The number of Americans with impaired vision or blindness is predicted to soar in coming decades as a result of age and chronic diseases, including diabetes. However, the nation's 19,000 ophthalmologists have access to a growing armamentarium of medications—with innovative delivery approaches—and state-of-the-art diagnostic and surgical technologies.

Chaired by Peter J. McDonnell, MD, director of the Wilmer Eye Institute, and Texas-based glaucoma specialist Oluwatosin U. Smith, MD, the Ophthalmology Times® EyeCon 2021 will bring together the nation’s top ophthalmology experts to share new data and clinical insight with learners who wish to deploy the most current processes and therapies for patients. Topics at the 2-day conference will include investigational and newly approved therapies for geographic atrophy, neovascular age-related macular degeneration, thyroid eye disease, and neuromyelitis optica spectrum disease; sustained drug delivery and minimally invasive surgery for glaucoma; advances in cataract and refractive surgery; gene therapy for retinal disease and other ocular conditions; and the latest strategies for managing common concerns, including uveitis, presbyopia, and dry eye disease.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Implement diagnostic approaches to correctly identify early presentations of both common and rare ocular diseases
• Apply recent guidelines and other evidence to the treatment of patients with vision changes and ocular diseases
• Demonstrate the ability to apply clinical trial data to optimize patient treatment in the eye-care setting
• Explain efficacy and trial data from recent clinical trials of investigational agents
• Identify the most appropriate strategies to improve vision outcomes in patients with common and unusual disease processes

Target Audience

This educational activity is directed toward ophthalmologists who treat patients with prevalent and rare ocular conditions. Other health care professionals interested in the treatment of eye diseases and injuries are also invited to participate.

You Will Learn To:

• Optimize the use of imaging and other diagnostic tools for earlier identification of ocular diseases
• Improve team-based interactions with other eye-care specialists and health care providers when treating patients with systemic diseases contributing to vision loss
• Gain confidence in the use of new and emerging therapies and procedures in the ophthalmology setting
• Interact with expert faculty to implement key learnings into practice

Join PER® for this virtual interactive event!

Access the latest insights and advancements during this high-impact CME meeting alongside our renowned faculty experts.

REGISTER NOW

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing Provider #16669, for 11.5
Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AbbVie Inc., Alcon Vision, LLC, Genentech, a member of the Roche Group, Johnson & Johnson Surgical Vision, Inc., and Santen.